MEDIA ADVISORY: Press Conference on Antibacterial agents in clinical and preclinical development report - 15 April

No images? Click here

Monday 12 April

MEDIA ADVISORY

Subject: Antibacterial agents in clinical and preclinical development report
Date and Time: 15 April 2021, 14:00 CEST (Geneva time)

On April 15th, 2021 the WHO will launch its new 2020 Antibacterial agents in clinical and preclinical development report. On the same day, the WHO will hold a one-hour press conference on the report at 14:00 CEST.

The report examines the current global development pipeline for new antibacterial treatments, including for tuberculosis, in the context of the silent pandemic of antibacterial resistance.

At the press conference, the WHO will briefly present the report highlighting some of the main results, this will be followed by a Q&A session.

Speakers:

Dr. Peter Beyer, Unit Head, Antimicrobial Resistance (AMR) Global coordination and Partnership (GCP)
Dr. Prabhavathi Fernandes, Chair of the Scientific Advisory Committee at the Global Antibiotic R&D Partnership (GARDP), and member of the WHO Advisory group on the Research and Development of Antibacterial Treatments
Dr. Henry B. Skinner, Chief Executive Officer (CEO), AMR Action Fund

Press release, the new report 2020 Antibacterial agents in clinical and preclinical development: an overview and analysis and infographics (UNDER EMBARGO until Thursday 15 April, 8:00 CEST) can be downloaded from here.

Join the press conference:

Link: https://who-e.zoom.us/j/95460962571

Password: p1p3l1ne

By phone:

Webinar ID: 954 6096 2571

Numeric passcode for phone: 49447917

International numbers available: https://who-e.zoom.us/u/acxzlAIA8B

Media contacts:
mediainquiries@who.int

You are receiving this NO-REPLY email because you are included on a WHO mail list.
If you have been forwarded this update you can click here to subscribe.
Journalists may send feedback to WHO Media Team